Notably, patients whose tumours simultaneously expressed Cav-1 and pERK-1/2 had a DFS of only 3.33 yrs versus 6.17 yrs (P = 0.001) for tumours either negative for one or both of the biomarkers (Figure 1K). Here, CAV1 is linked to neoplasm.